| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.21e-09 | 26 | 38 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC22A16 SLC16A1 SLC39A5 ABCA7 CALHM1 SLC16A8 SLC26A5 SCN8A SCN9A | 1.46e-09 | 1180 | 38 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC22A16 SLC16A1 SLC39A5 ABCA7 CALHM1 SLC16A8 SLC26A5 SCN8A SCN9A | 4.90e-09 | 1289 | 38 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 6.36e-09 | 3 | 38 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC16A1 SLC39A5 CALHM1 SLC26A5 SCN8A SCN9A | 8.96e-09 | 758 | 38 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC16A1 SLC39A5 CALHM1 SLC26A5 SCN8A SCN9A | 1.48e-08 | 793 | 38 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC16A1 SLC39A5 CALHM1 SCN8A SCN9A | 1.49e-08 | 627 | 38 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC16A1 SLC39A5 CALHM1 SCN8A SCN9A | 2.69e-08 | 664 | 38 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.01e-08 | 171 | 38 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.62e-08 | 52 | 38 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1I CACNA1H CACNA1G SLC9A3 SLC10A1 SLC39A5 CALHM1 SCN8A SCN9A | 1.67e-07 | 465 | 38 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.25e-06 | 296 | 38 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.72e-06 | 46 | 38 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.28e-06 | 14 | 38 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A1 SLC9A3 SLC10A1 SLC16A1 SLC39A5 ABCA7 SLC16A8 SLC26A5 | 2.60e-06 | 477 | 38 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | 9.20e-06 | 150 | 38 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.76e-05 | 293 | 38 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.05e-05 | 301 | 38 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 2.75e-05 | 31 | 38 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | exogenous lipid antigen binding | 3.51e-05 | 5 | 38 | 2 | GO:0030884 | |
| GeneOntologyMolecularFunction | endogenous lipid antigen binding | 3.51e-05 | 5 | 38 | 2 | GO:0030883 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.27e-05 | 343 | 38 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.33e-05 | 207 | 38 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.44e-05 | 208 | 38 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 5.26e-05 | 6 | 38 | 2 | GO:0030882 | |
| GeneOntologyMolecularFunction | lactate transmembrane transporter activity | 5.26e-05 | 6 | 38 | 2 | GO:0015129 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.57e-05 | 119 | 38 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.04e-04 | 129 | 38 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 1.57e-04 | 10 | 38 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.90e-04 | 151 | 38 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.95e-04 | 152 | 38 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.11e-04 | 459 | 38 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.16e-04 | 14 | 38 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 3.19e-04 | 70 | 38 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.87e-04 | 182 | 38 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.03e-04 | 184 | 38 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | channel activity | 4.33e-04 | 525 | 38 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.38e-04 | 526 | 38 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 5.91e-04 | 19 | 38 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 6.66e-04 | 90 | 38 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 1.03e-03 | 25 | 38 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.11e-03 | 26 | 38 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.69e-03 | 32 | 38 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.79e-03 | 33 | 38 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.62e-03 | 334 | 38 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 5.44e-03 | 188 | 38 | 3 | GO:0015078 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.35e-02 | 93 | 38 | 2 | GO:0097110 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 5.84e-09 | 36 | 38 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC22A16 SLC16A1 SLC39A5 CALHM1 IL4 SLC26A5 SCN8A SCN9A | 6.73e-08 | 1374 | 38 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.05e-07 | 63 | 38 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC16A1 SLC39A5 CALHM1 IL4 SLC26A5 SCN8A SCN9A | 1.59e-07 | 1017 | 38 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC16A1 SLC39A5 CALHM1 IL4 SLC26A5 SCN8A SCN9A | 4.29e-07 | 1115 | 38 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC16A1 SLC39A5 CALHM1 IL4 SCN8A SCN9A | 5.32e-07 | 922 | 38 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | sodium ion transport | 6.15e-07 | 275 | 38 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC16A1 SLC39A5 CALHM1 IL4 SCN8A SCN9A | 6.37e-07 | 1157 | 38 | 12 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC16A1 SLC39A5 CALHM1 IL4 SCN8A SCN9A | 6.58e-07 | 942 | 38 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.88e-06 | 112 | 38 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.06e-06 | 208 | 38 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.75e-06 | 121 | 38 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC46A1 SLC10A1 KISS1R SLC16A1 SLC39A5 CALHM1 SLC16A8 SLC26A5 | 3.62e-06 | 515 | 38 | 8 | GO:0015711 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 3.69e-06 | 230 | 38 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 6.02e-06 | 142 | 38 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 6.02e-06 | 142 | 38 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion-dependent exocytosis | 6.44e-06 | 20 | 38 | 3 | GO:0045956 | |
| GeneOntologyBiologicalProcess | positive regulation of regulated secretory pathway | 6.50e-06 | 66 | 38 | 4 | GO:1903307 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1I CACNA1H CACNA1G SLC46A1 SLC9A3 SLC10A1 SLC39A5 CALHM1 SCN8A SCN9A | 9.37e-06 | 1000 | 38 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.54e-05 | 93 | 38 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | action potential | 3.23e-05 | 201 | 38 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | 3.29e-05 | 5 | 38 | 2 | GO:0048006 | |
| GeneOntologyBiologicalProcess | positive regulation of exocytosis | 4.41e-05 | 107 | 38 | 4 | GO:0045921 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 6.90e-05 | 7 | 38 | 2 | GO:0048007 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of lipid antigen via MHC class Ib | 6.90e-05 | 7 | 38 | 2 | GO:0048003 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 7.76e-05 | 45 | 38 | 3 | GO:0017158 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.60e-05 | 127 | 38 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta clearance | 9.19e-05 | 8 | 38 | 2 | GO:1900223 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 9.42e-05 | 48 | 38 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 9.42e-05 | 48 | 38 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 9.58e-05 | 410 | 38 | 6 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 9.84e-05 | 412 | 38 | 6 | GO:0015849 | |
| GeneOntologyBiologicalProcess | lactate transport | 1.18e-04 | 9 | 38 | 2 | GO:0015727 | |
| GeneOntologyBiologicalProcess | lactate transmembrane transport | 1.18e-04 | 9 | 38 | 2 | GO:0035873 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.77e-04 | 153 | 38 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 2.02e-04 | 62 | 38 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.25e-04 | 163 | 38 | 4 | GO:0002456 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 2.36e-04 | 165 | 38 | 4 | GO:1903305 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.47e-04 | 167 | 38 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 2.64e-04 | 170 | 38 | 4 | GO:1902600 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 2.90e-04 | 70 | 38 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.42e-04 | 74 | 38 | 3 | GO:0002711 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide salvage | 3.90e-04 | 16 | 38 | 2 | GO:0106380 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 4.62e-04 | 82 | 38 | 3 | GO:0017156 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 5.09e-04 | 559 | 38 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.50e-04 | 87 | 38 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | purine nucleotide salvage | 5.54e-04 | 19 | 38 | 2 | GO:0032261 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 5.71e-04 | 801 | 38 | 7 | GO:0051046 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta clearance | 6.15e-04 | 20 | 38 | 2 | GO:1900221 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 6.20e-04 | 213 | 38 | 4 | GO:0015718 | |
| GeneOntologyBiologicalProcess | import into cell | 6.37e-04 | 1074 | 38 | 8 | GO:0098657 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 6.65e-04 | 217 | 38 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | purine-containing compound salvage | 7.46e-04 | 22 | 38 | 2 | GO:0043101 | |
| GeneOntologyBiologicalProcess | calcium ion import | 7.78e-04 | 98 | 38 | 3 | GO:0070509 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate biosynthetic process | 8.16e-04 | 23 | 38 | 2 | GO:0009168 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 8.29e-04 | 404 | 38 | 5 | GO:1903532 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 8.67e-04 | 233 | 38 | 4 | GO:0017157 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 9.65e-04 | 25 | 38 | 2 | GO:0002475 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate biosynthetic process | 9.65e-04 | 25 | 38 | 2 | GO:0009127 | |
| GeneOntologyBiologicalProcess | nucleotide salvage | 1.04e-03 | 26 | 38 | 2 | GO:0043173 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.12e-03 | 111 | 38 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 1.15e-03 | 435 | 38 | 5 | GO:0051047 | |
| GeneOntologyBiologicalProcess | AMP metabolic process | 1.39e-03 | 30 | 38 | 2 | GO:0046033 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 1.40e-03 | 120 | 38 | 3 | GO:0006835 | |
| GeneOntologyBiologicalProcess | secretion | 1.47e-03 | 1221 | 38 | 8 | GO:0046903 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.58e-03 | 32 | 38 | 2 | GO:0019883 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 1.96e-03 | 291 | 38 | 4 | GO:0045055 | |
| GeneOntologyBiologicalProcess | heart contraction | 2.14e-03 | 298 | 38 | 4 | GO:0060047 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.16e-03 | 740 | 38 | 6 | GO:1903530 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 2.23e-03 | 38 | 38 | 2 | GO:0015701 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate biosynthetic process | 2.23e-03 | 38 | 38 | 2 | GO:0009156 | |
| GeneOntologyBiologicalProcess | cell killing | 2.38e-03 | 307 | 38 | 4 | GO:0001906 | |
| GeneOntologyBiologicalProcess | heart process | 2.44e-03 | 309 | 38 | 4 | GO:0003015 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 2.47e-03 | 40 | 38 | 2 | GO:0097242 | |
| GeneOntologyBiologicalProcess | cellular metabolic compound salvage | 2.47e-03 | 40 | 38 | 2 | GO:0043094 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 2.49e-03 | 147 | 38 | 3 | GO:0031341 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.64e-03 | 150 | 38 | 3 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 2.64e-03 | 150 | 38 | 3 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.72e-03 | 42 | 38 | 2 | GO:0001916 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 2.72e-03 | 42 | 38 | 2 | GO:0060402 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 2.98e-03 | 44 | 38 | 2 | GO:0072337 | |
| GeneOntologyBiologicalProcess | sensory perception | 3.08e-03 | 1072 | 38 | 7 | GO:0007600 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 3.11e-03 | 159 | 38 | 3 | GO:0002821 | |
| GeneOntologyBiologicalProcess | muscle system process | 3.14e-03 | 547 | 38 | 5 | GO:0003012 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.05e-10 | 17 | 39 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.99e-09 | 29 | 39 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.86e-06 | 320 | 39 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.63e-06 | 354 | 39 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 5.59e-06 | 378 | 39 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | cation channel complex | 7.25e-05 | 235 | 39 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 8.62e-05 | 46 | 39 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.41e-04 | 73 | 39 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.54e-04 | 378 | 39 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.01e-03 | 487 | 39 | 5 | GO:0016324 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.74e-03 | 523 | 39 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 3.41e-03 | 550 | 39 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | cell surface | 4.06e-03 | 1111 | 39 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | apical part of cell | 4.65e-03 | 592 | 39 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | endosome membrane | 4.99e-03 | 602 | 39 | 5 | GO:0010008 | |
| MousePheno | abnormal action potential | 1.18e-05 | 133 | 32 | 5 | MP:0005402 | |
| MousePheno | abnormal single cell response | 6.79e-05 | 35 | 32 | 3 | MP:0003463 | |
| Domain | VDCC_T_a1 | 7.77e-09 | 3 | 38 | 3 | IPR005445 | |
| Domain | Channel_four-helix_dom | 1.03e-07 | 57 | 38 | 5 | IPR027359 | |
| Domain | - | 1.03e-07 | 57 | 38 | 5 | 1.20.120.350 | |
| Domain | VDCCAlpha1 | 9.23e-07 | 10 | 38 | 3 | IPR002077 | |
| Domain | Ion_trans_dom | 3.32e-06 | 114 | 38 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.32e-06 | 114 | 38 | 5 | PF00520 | |
| Domain | MCT | 4.02e-05 | 5 | 38 | 2 | IPR004743 | |
| Domain | Na_trans_cytopl | 6.02e-05 | 6 | 38 | 2 | PF11933 | |
| Domain | MHC_I_3 | 6.02e-05 | 6 | 38 | 2 | PF16497 | |
| Domain | Na_trans_cytopl | 6.02e-05 | 6 | 38 | 2 | IPR024583 | |
| Domain | MFS | 6.71e-05 | 108 | 38 | 4 | PS50850 | |
| Domain | MFS_dom | 1.55e-04 | 134 | 38 | 4 | IPR020846 | |
| Domain | Na_channel_asu | 1.80e-04 | 10 | 38 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.80e-04 | 10 | 38 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.80e-04 | 10 | 38 | 2 | PF06512 | |
| Domain | MFS | 5.12e-04 | 77 | 38 | 3 | IPR011701 | |
| Domain | MFS_1 | 5.12e-04 | 77 | 38 | 3 | PF07690 | |
| Domain | - | 1.08e-03 | 24 | 38 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.08e-03 | 24 | 38 | 2 | IPR011161 | |
| Domain | MHC_I/II-like_Ag-recog | 2.71e-03 | 38 | 38 | 2 | IPR011162 | |
| Domain | C1-set | 5.40e-03 | 54 | 38 | 2 | PF07654 | |
| Domain | IGc1 | 5.79e-03 | 56 | 38 | 2 | SM00407 | |
| Domain | Ig_C1-set | 6.20e-03 | 58 | 38 | 2 | IPR003597 | |
| Domain | IQ | 9.17e-03 | 71 | 38 | 2 | PF00612 | |
| Domain | IQ | 1.18e-02 | 81 | 38 | 2 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.44e-02 | 90 | 38 | 2 | IPR000048 | |
| Domain | IQ | 1.53e-02 | 93 | 38 | 2 | PS50096 | |
| Domain | Ankyrin_rpt | 1.60e-02 | 262 | 38 | 3 | IPR002110 | |
| Domain | EF-hand-dom_pair | 2.04e-02 | 287 | 38 | 3 | IPR011992 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.66e-05 | 23 | 31 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.14e-05 | 25 | 31 | 3 | M47948 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.26e-05 | 84 | 31 | 4 | M27334 | |
| Pathway | REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT | 6.98e-05 | 6 | 31 | 2 | MM17217 | |
| Pathway | REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT | 6.98e-05 | 6 | 31 | 2 | M27355 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 7.38e-05 | 203 | 31 | 5 | M5485 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.04e-04 | 42 | 31 | 3 | M7169 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.12e-04 | 43 | 31 | 3 | M1429 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.93e-04 | 249 | 31 | 5 | M5988 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.50e-04 | 63 | 31 | 3 | M11187 | |
| Pathway | REACTOME_PURINE_SALVAGE | 3.60e-04 | 13 | 31 | 2 | MM15438 | |
| Pathway | REACTOME_PURINE_SALVAGE | 3.60e-04 | 13 | 31 | 2 | M814 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 6.07e-04 | 76 | 31 | 3 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 8.99e-04 | 736 | 31 | 7 | M27287 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 9.01e-04 | 87 | 31 | 3 | M6856 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 1.15e-03 | 23 | 31 | 2 | M27831 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 1.15e-03 | 23 | 31 | 2 | MM15552 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 1.25e-03 | 24 | 31 | 2 | MM17215 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 1.36e-03 | 25 | 31 | 2 | M4974 | |
| Pathway | REACTOME_DRUG_ADME | 1.73e-03 | 109 | 31 | 3 | M45012 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.74e-03 | 238 | 31 | 4 | MM15076 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.09e-03 | 31 | 31 | 2 | M877 | |
| Pathway | REACTOME_DRUG_ADME | 2.22e-03 | 119 | 31 | 3 | MM15692 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.23e-03 | 32 | 31 | 2 | M27455 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.25e-03 | 681 | 31 | 6 | MM14985 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.30e-09 | 3 | 39 | 3 | 23488970 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 1.30e-09 | 3 | 39 | 3 | 18591418 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.30e-09 | 3 | 39 | 3 | 11230107 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 28846697 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.30e-09 | 3 | 39 | 3 | 28972185 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 11927664 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 11897840 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 5.21e-09 | 4 | 39 | 3 | 28165634 | |
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 28330839 | ||
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 34478646 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 7.27e-08 | 8 | 39 | 3 | 12761855 | |
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 16382099 | ||
| Pubmed | 1.56e-07 | 10 | 39 | 3 | 24778262 | ||
| Pubmed | 1.05e-06 | 18 | 39 | 3 | 31791063 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.23e-06 | 2 | 39 | 2 | 12808460 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14988077 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21622683 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 10899914 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25071191 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20685979 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 36786913 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26627919 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22469755 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23436820 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21079360 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31042060 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22886848 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.23e-06 | 2 | 39 | 2 | 27174182 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29082441 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22574369 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 34399820 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 1.23e-06 | 2 | 39 | 2 | 21438841 | |
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 1.23e-06 | 2 | 39 | 2 | 22808078 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24327205 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24966091 | ||
| Pubmed | Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. | 3.67e-06 | 3 | 39 | 2 | 14551186 | |
| Pubmed | Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels. | 3.67e-06 | 3 | 39 | 2 | 21084288 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 33299036 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 33384157 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 16514190 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22572848 | ||
| Pubmed | Inhibition of CD1 antigen presentation by human cytomegalovirus. | 3.67e-06 | 3 | 39 | 2 | 18287231 | |
| Pubmed | Separate pathways for antigen presentation by CD1 molecules. | 3.67e-06 | 3 | 39 | 2 | 10626896 | |
| Pubmed | CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. | 3.67e-06 | 3 | 39 | 2 | 16272286 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27353765 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31919478 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 25825486 | ||
| Pubmed | Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease. | 3.67e-06 | 3 | 39 | 2 | 15556687 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 37739992 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23468110 | ||
| Pubmed | Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. | 3.67e-06 | 3 | 39 | 2 | 2447586 | |
| Pubmed | Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. | 3.67e-06 | 3 | 39 | 2 | 23766460 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15302875 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 18624350 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 31800012 | ||
| Pubmed | Antigen presentation by CD1 and MHC-encoded class I-like molecules. | 7.34e-06 | 4 | 39 | 2 | 8729450 | |
| Pubmed | Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. | 7.34e-06 | 4 | 39 | 2 | 24556395 | |
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 7.34e-06 | 4 | 39 | 2 | 21788606 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12657613 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 28655554 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 2701945 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12415264 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 3097645 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 18337560 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.22e-05 | 5 | 39 | 2 | 22875929 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12056458 | ||
| Pubmed | A physical map linking the five CD1 human thymocyte differentiation antigen genes. | 1.22e-05 | 5 | 39 | 2 | 2583117 | |
| Pubmed | CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. | 1.22e-05 | 5 | 39 | 2 | 11580851 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 33999492 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 10488738 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12060068 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 23677998 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 15032598 | ||
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 1.22e-05 | 5 | 39 | 2 | 29720258 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.80e-05 | 139 | 39 | 4 | 16985003 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 16029194 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 15917240 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 1.83e-05 | 6 | 39 | 2 | 17513486 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.83e-05 | 6 | 39 | 2 | 23652591 | |
| Pubmed | 2.02e-05 | 143 | 39 | 4 | 20424473 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 12900400 | ||
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 16382098 | ||
| Pubmed | An interspecific backcross linkage map of the proximal half of mouse chromosome 14. | 5.48e-05 | 10 | 39 | 2 | 1971251 | |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 7.37e-05 | 72 | 39 | 3 | 25917818 | |
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 7273846 | ||
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 15123669 | ||
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 12739169 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 28112518 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.65e-04 | 17 | 39 | 2 | 27725084 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 8.40e-04 | 38 | 39 | 2 | 30786075 | |
| Pubmed | 8.40e-04 | 38 | 39 | 2 | 18407958 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 1.04e-03 | 697 | 39 | 5 | 28298427 | |
| Cytoband | 1q22-q23 | 5.45e-05 | 13 | 39 | 2 | 1q22-q23 | |
| Cytoband | 17q22 | 6.50e-04 | 44 | 39 | 2 | 17q22 | |
| Cytoband | 12q24.31 | 2.13e-03 | 80 | 39 | 2 | 12q24.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.55e-03 | 423 | 39 | 3 | chr12q13 | |
| GeneFamily | Solute carriers | SLC46A1 SLC9A3 SLC10A1 SLC22A16 SLC16A1 SLC39A5 SLC16A8 SLC26A5 | 5.35e-08 | 395 | 26 | 8 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 6.71e-06 | 26 | 26 | 3 | 253 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.11e-05 | 9 | 26 | 2 | 1203 | |
| GeneFamily | C1-set domain containing | 1.65e-03 | 42 | 26 | 2 | 591 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_DN | 1.07e-05 | 197 | 39 | 5 | M5691 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 5.28e-07 | 182 | 39 | 5 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 5.72e-07 | 185 | 39 | 5 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh|GI_small-bowel / Manually curated celltypes from each tissue | 5.71e-06 | 134 | 39 | 4 | bf94ce5edde8912a27010e229c313d8102d6de62 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Dditl_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 52 | 39 | 3 | f72bbaf941a1e499a25a54bf1da51d960df946e8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 53 | 39 | 3 | 2147787ed3de18b49f51a8518984c7b6ba9a8cef | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.53e-05 | 172 | 39 | 4 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.83e-05 | 180 | 39 | 4 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 1.91e-05 | 182 | 39 | 4 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-05 | 184 | 39 | 4 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-05 | 184 | 39 | 4 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.99e-05 | 184 | 39 | 4 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 2.03e-05 | 185 | 39 | 4 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.08e-05 | 186 | 39 | 4 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.08e-05 | 186 | 39 | 4 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.12e-05 | 187 | 39 | 4 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.12e-05 | 187 | 39 | 4 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.17e-05 | 188 | 39 | 4 | 6b0e0192519ea3ca49fb21de3da9a0a108fcb64d | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.17e-05 | 188 | 39 | 4 | 0b19c35fdc2b9e064e8f03ef69ae08644794ec24 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.26e-05 | 190 | 39 | 4 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.35e-05 | 192 | 39 | 4 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 2.40e-05 | 193 | 39 | 4 | 7bce609699c515d2d114596a0c527f90cc09c4af | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-05 | 194 | 39 | 4 | e56c6e5c9b7d287ae94566b561e21cec2055f83d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.50e-05 | 195 | 39 | 4 | 85fee07d71c0393ea42bcf1130566dff4a62f507 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.76e-05 | 200 | 39 | 4 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, condition lineage and cell class | 2.76e-05 | 200 | 39 | 4 | 59cb0b0dee2599b3d3014b66d71d84c22b5de4b2 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 112 | 39 | 3 | 32c6ab8e9b71c6c3df7e3e119b88e6ad1b895d50 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.64e-04 | 143 | 39 | 3 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.75e-04 | 145 | 39 | 3 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 146 | 39 | 3 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 147 | 39 | 3 | 22c9605869dd2e789896cd2790ee8def2605de57 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 147 | 39 | 3 | ac272595818d25c6b84b107555b3351e912a01a7 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 150 | 39 | 3 | fdbfc8f743cf848978cf0488493f6df60be53982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 152 | 39 | 3 | eee86b508b8f140ea44e21d8c04c409a7b689e39 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-04 | 154 | 39 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.28e-04 | 154 | 39 | 3 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-04 | 154 | 39 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.35e-04 | 155 | 39 | 3 | 9a27558c457f05808af07190b7a5006b047f1d58 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.35e-04 | 155 | 39 | 3 | ab539c04f10276ae919d82b1c75f99a84eb695bf | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.41e-04 | 156 | 39 | 3 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 156 | 39 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.41e-04 | 156 | 39 | 3 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class | 3.54e-04 | 158 | 39 | 3 | 71af1319eec34bf7bc9361ec9ef720c280ce97d1 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 3.67e-04 | 160 | 39 | 3 | 1b73a14ad6546d9f2812c19081278a79260abeae | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.81e-04 | 162 | 39 | 3 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 3.95e-04 | 164 | 39 | 3 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 3.95e-04 | 164 | 39 | 3 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-04 | 165 | 39 | 3 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | Influenza_Severe-cDC|Influenza_Severe / Disease group and Cell class | 4.09e-04 | 166 | 39 | 3 | b40bdf0f7f381e25be61188e9f6c294d25a8b824 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, Lineage and Cell Type | 4.16e-04 | 167 | 39 | 3 | 5b7b731944d888591279ef6167b3ae8cab3f6886 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-04 | 167 | 39 | 3 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-04 | 167 | 39 | 3 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | severe-Myeloid-mDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.16e-04 | 167 | 39 | 3 | 50b1cea9048bd8df9aff3fb9a548443f950d1090 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | 18c266162a879544c0103d9dff0270af68964f9e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.23e-04 | 168 | 39 | 3 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | cb1506cd43a4f36f9024cc9b8e5319365498d244 | |
| ToppCell | severe-Myeloid-mDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.23e-04 | 168 | 39 | 3 | eff37a92d41624924201372cc09f9eb07b60aec1 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-04 | 168 | 39 | 3 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.31e-04 | 169 | 39 | 3 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-04 | 171 | 39 | 3 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-04 | 172 | 39 | 3 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 173 | 39 | 3 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.61e-04 | 173 | 39 | 3 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.61e-04 | 173 | 39 | 3 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-04 | 174 | 39 | 3 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-04 | 174 | 39 | 3 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-04 | 174 | 39 | 3 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-04 | 174 | 39 | 3 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 4.77e-04 | 175 | 39 | 3 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-04 | 175 | 39 | 3 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-04 | 176 | 39 | 3 | e7502a345b2da83a9a60f50cf78f1aef385c99df | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-04 | 176 | 39 | 3 | 6b04672f295d7680ba00714a72785314a619c893 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 4.85e-04 | 176 | 39 | 3 | de67ed15a50d2515ba6d152c1011a3367f77aedd | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 176 | 39 | 3 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 176 | 39 | 3 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.93e-04 | 177 | 39 | 3 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.93e-04 | 177 | 39 | 3 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.93e-04 | 177 | 39 | 3 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.93e-04 | 177 | 39 | 3 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.93e-04 | 177 | 39 | 3 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 180 | 39 | 3 | 702673c0b7c5b0d22a6af3884374804b8c4d6254 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-04 | 180 | 39 | 3 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 5.18e-04 | 180 | 39 | 3 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-04 | 180 | 39 | 3 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 181 | 39 | 3 | c7a220891567c7539ad5a9ac9db375f0de08ea00 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-04 | 183 | 39 | 3 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 5.43e-04 | 183 | 39 | 3 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-04 | 183 | 39 | 3 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 5.43e-04 | 183 | 39 | 3 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-04 | 184 | 39 | 3 | 780d67f04fc795f614e077d8a5cf368542f6d99d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.52e-04 | 184 | 39 | 3 | e5756afa3181186f9b65552b8df5359ef4024bee | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.52e-04 | 184 | 39 | 3 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.52e-04 | 184 | 39 | 3 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.52e-04 | 184 | 39 | 3 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.52e-04 | 184 | 39 | 3 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| Computational | Genes in the cancer module 186. | 6.15e-06 | 20 | 20 | 3 | MODULE_186 | |
| Computational | Genes in the cancer module 71. | 8.29e-06 | 22 | 20 | 3 | MODULE_71 | |
| Computational | Peptide and AA transporters. | 4.94e-04 | 18 | 20 | 2 | MODULE_368 | |
| Computational | Genes in the cancer module 218. | 6.13e-04 | 20 | 20 | 2 | MODULE_218 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 4.65e-09 | 3 | 39 | 3 | CID010679219 | |
| Drug | Zonisamide | 1.72e-08 | 17 | 39 | 4 | DB00909 | |
| Drug | Flunarizine | 4.64e-08 | 5 | 39 | 3 | DB04841 | |
| Drug | 3,4-dihydroquinazoline | 9.26e-08 | 6 | 39 | 3 | CID000583065 | |
| Drug | LY215840 | 1.62e-07 | 7 | 39 | 3 | CID000132049 | |
| Drug | Cinnarizine | 3.88e-07 | 9 | 39 | 3 | DB00568 | |
| Drug | Mibefradil | 7.59e-07 | 11 | 39 | 3 | DB01388 | |
| Drug | EBNs | 7.59e-07 | 11 | 39 | 3 | CID000150695 | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.00e-06 | 197 | 39 | 6 | 4585_UP | |
| Drug | AC1L2VU3 | 1.01e-06 | 12 | 39 | 3 | CID000129572 | |
| Drug | themisone | 1.01e-06 | 12 | 39 | 3 | CID000016235 | |
| Drug | tetralol | 1.31e-06 | 13 | 39 | 3 | CID000010747 | |
| Drug | Mibefradil | 1.31e-06 | 13 | 39 | 3 | ctd:D020748 | |
| Drug | pentasulfane | 2.56e-06 | 16 | 39 | 3 | CID000448216 | |
| Drug | zonisamide | 3.82e-06 | 62 | 39 | 4 | CID000005734 | |
| Drug | cyclopropanecarboxylic acid | 4.42e-06 | 19 | 39 | 3 | CID000015655 | |
| Drug | SureCN2398996 | 8.57e-06 | 3 | 39 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 8.57e-06 | 3 | 39 | 2 | CID000092154 | |
| Drug | hydroxamates | 1.04e-05 | 25 | 39 | 3 | CID000033630 | |
| Drug | riluzole | 1.15e-05 | 174 | 39 | 5 | CID000005070 | |
| Drug | Sodium | 1.28e-05 | 84 | 39 | 4 | ctd:D012964 | |
| Drug | rufinamide | 1.65e-05 | 29 | 39 | 3 | CID000129228 | |
| Drug | methsuximide | 1.71e-05 | 4 | 39 | 2 | CID000006476 | |
| Drug | anacardic acid | 1.83e-05 | 30 | 39 | 3 | CID000167551 | |
| Drug | oxcarbazepine | 1.83e-05 | 30 | 39 | 3 | CID000034312 | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 5089_UP | |
| Drug | CNS 1145 | 2.45e-05 | 33 | 39 | 3 | CID000190902 | |
| Drug | IHC-64 | 2.45e-05 | 33 | 39 | 3 | CID000162753 | |
| Drug | isradipine | 2.56e-05 | 100 | 39 | 4 | CID000003784 | |
| Drug | AC1O7G5C | 2.85e-05 | 5 | 39 | 2 | CID006603942 | |
| Drug | phensuximide | 2.85e-05 | 5 | 39 | 2 | CID000006839 | |
| Drug | T3-A | 3.19e-05 | 36 | 39 | 3 | CID000121591 | |
| Drug | pyraclofos | 3.22e-05 | 106 | 39 | 4 | CID000093460 | |
| Drug | phenytoin | 3.47e-05 | 219 | 39 | 5 | CID000001775 | |
| Drug | AC1MQ5W8 | 4.27e-05 | 6 | 39 | 2 | CID003396482 | |
| Drug | cerebrocrast | 4.27e-05 | 6 | 39 | 2 | CID000159556 | |
| Drug | ethyl phosphate | 4.27e-05 | 6 | 39 | 2 | CID000074190 | |
| Drug | L-708,906 | 4.27e-05 | 6 | 39 | 2 | CID000475514 | |
| Drug | Tetrodotoxin | 4.39e-05 | 40 | 39 | 3 | ctd:D013779 | |
| Drug | lamotrigine | 4.58e-05 | 116 | 39 | 4 | CID000003878 | |
| Drug | coaristeromycin | 5.97e-05 | 7 | 39 | 2 | CID000097182 | |
| Drug | losigamone | 5.97e-05 | 7 | 39 | 2 | CID000060572 | |
| Drug | bepridil | 6.33e-05 | 126 | 39 | 4 | CID000002351 | |
| Drug | KW-3049 | 8.61e-05 | 50 | 39 | 3 | CID000002324 | |
| Drug | dimethylmercury | 9.69e-05 | 52 | 39 | 3 | CID000011645 | |
| Drug | N-hydroxyglycine | 1.02e-04 | 9 | 39 | 2 | CID000019070 | |
| Drug | Landel | 1.02e-04 | 9 | 39 | 2 | CID000163838 | |
| Drug | isovalerate | 1.03e-04 | 143 | 39 | 4 | CID000010430 | |
| Drug | N-methyl-DL-aspartic acid | 1.09e-04 | 655 | 39 | 7 | CID000004376 | |
| Drug | Cinildipine | 1.21e-04 | 56 | 39 | 3 | CID000002752 | |
| Drug | AC1NRAKH | 1.28e-04 | 57 | 39 | 3 | CID005287950 | |
| Drug | ZD7288 | 1.28e-04 | 10 | 39 | 2 | CID000123983 | |
| Drug | procaine | 1.34e-04 | 153 | 39 | 4 | CID000004914 | |
| Drug | nilvadipine | 1.49e-04 | 60 | 39 | 3 | CID000004494 | |
| Drug | I16-1 | 1.56e-04 | 11 | 39 | 2 | CID000061078 | |
| Drug | arachidonoylglycine | 1.56e-04 | 11 | 39 | 2 | CID000004345 | |
| Drug | IAA-94 | 1.56e-04 | 61 | 39 | 3 | CID000003667 | |
| Drug | lercanidipine | 1.72e-04 | 63 | 39 | 3 | CID000065866 | |
| Drug | Calcium | 1.78e-04 | 493 | 39 | 6 | ctd:D002118 | |
| Drug | mibefradil | 1.80e-04 | 64 | 39 | 3 | CID000060662 | |
| Drug | 1,6-hexamethylene diisocyanate | 1.89e-04 | 65 | 39 | 3 | ctd:C015262 | |
| Drug | gabapentin | 1.97e-04 | 169 | 39 | 4 | CID000003446 | |
| Drug | AC1L1TJF | 1.97e-04 | 66 | 39 | 3 | CID000003377 | |
| Drug | gallopamil | 2.06e-04 | 67 | 39 | 3 | CID000001234 | |
| Drug | isothiazole | 2.20e-04 | 13 | 39 | 2 | CID000067515 | |
| Drug | AC1L2AC7 | 2.25e-04 | 69 | 39 | 3 | CID000068733 | |
| Drug | Barium | 2.55e-04 | 72 | 39 | 3 | ctd:D001464 | |
| Drug | Pyruvic acid | 2.57e-04 | 14 | 39 | 2 | DB00119 | |
| Drug | bioallethrin | 2.57e-04 | 14 | 39 | 2 | ctd:C018465 | |
| Drug | NSC7524 | 2.61e-04 | 182 | 39 | 4 | CID000005657 | |
| Drug | CAS 298-57-7 | 2.66e-04 | 73 | 39 | 3 | CID000002761 | |
| Drug | ethosuximide | 2.77e-04 | 74 | 39 | 3 | CID000003291 | |
| Drug | CoCl2 | 2.88e-04 | 75 | 39 | 3 | CID003015678 | |
| Drug | butamben | 2.96e-04 | 15 | 39 | 2 | CID000002482 | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.14e-04 | 191 | 39 | 4 | 2771_UP | |
| Drug | NSC759576 | 3.14e-04 | 191 | 39 | 4 | CID000003075 | |
| Drug | nisoldipine | 3.23e-04 | 78 | 39 | 3 | CID000004499 | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 5936_UP | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 3.36e-04 | 79 | 39 | 3 | CID005287890 | |
| Drug | 3-deazaadenine | 3.38e-04 | 16 | 39 | 2 | CID000418745 | |
| Drug | hadacidin | 3.38e-04 | 16 | 39 | 2 | CID000012717 | |
| Drug | Verapamil | 3.38e-04 | 16 | 39 | 2 | DB00661 | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 4402_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 1517_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 2233_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; HL60; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 2726_UP | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 3394_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 4167_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 4407_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4673_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 5076_UP | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 2822_DN | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; HL60; HG-U133A | 3.53e-04 | 197 | 39 | 4 | 1711_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 4811_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 2271_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 7322_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6026_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 7331_UP | |
| Drug | lactofen | 3.61e-04 | 81 | 39 | 3 | CID000062276 | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 4115_UP | |
| Disease | B Virus Infection | 4.59e-06 | 3 | 37 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 4.59e-06 | 3 | 37 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 4.59e-06 | 3 | 37 | 2 | C0019372 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.84e-05 | 10 | 37 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.84e-05 | 10 | 37 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.00e-04 | 12 | 37 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Mental Retardation, Psychosocial | 7.07e-04 | 139 | 37 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 7.07e-04 | 139 | 37 | 3 | C0020796 | |
| Disease | Mental deficiency | 7.07e-04 | 139 | 37 | 3 | C0917816 | |
| Disease | Dermatitis, Atopic | 9.38e-04 | 36 | 37 | 2 | C0011615 | |
| Disease | Eczema, Infantile | 9.38e-04 | 36 | 37 | 2 | C0086196 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IGILQLAFFNIPLMA | 531 | Q0P6H9 | |
| LRENILFGMGNPLLD | 21 | P55263 | |
| MQPFLLLLAFLLTPG | 1 | P20718 | |
| FLAEMLLQAGLPLGQ | 231 | Q8TC94 | |
| PLVLFLLGLVMNNNV | 61 | Q8IU99 | |
| MLLLPFQLLAVLFPG | 1 | P29016 | |
| GKNLLAMVIQGPLFL | 1731 | Q8IZY2 | |
| LPNFGKMLENIFLPL | 486 | Q01432 | |
| LGLALNFQPSLIMLG | 121 | O95907 | |
| PLFIGFIGLGLSLML | 71 | P56975 | |
| GLGLAFNLNPALTMI | 121 | P53985 | |
| MKGFPFLLGAGLLLI | 421 | Q96NT5 | |
| IPLLFLQNITGFMVG | 396 | Q9HCC0 | |
| PLGLFQLDALMFLRL | 466 | Q38SD2 | |
| PLFFAALMLLGLVGN | 46 | Q969F8 | |
| GLLQKLLGFNMIPYL | 1981 | P50748 | |
| MPNPLVNLNLGLLFI | 91 | P03886 | |
| FLIIFPPLLMGLQLD | 151 | A6NCV1 | |
| PLLYMIFQLGEGLLL | 286 | Q14973 | |
| MGLTSQLLPPLFFLL | 1 | P05112 | |
| VMQALPQVGNLGLLF | 1736 | O43497 | |
| PQVGNLGLLFMLLFF | 1741 | O43497 | |
| MLFLQFLLLALLLPG | 1 | P29017 | |
| LPQVGNLGLLFMLLF | 1616 | Q9P0X4 | |
| LPQVGNLGLLFMLLF | 1746 | O95180 | |
| GQTLPLGFMVNLLAL | 316 | A6NKF1 | |
| LFLLFLPAGLLAQGQ | 6 | P55001 | |
| FLLLGFLLGPRIQML | 11 | Q8NGT9 | |
| FLLGPRIQMLLFGLF | 16 | Q8NGT9 | |
| FLLLGFPIGPRIQML | 11 | A4D2G3 | |
| FPIGPRIQMLLFGLF | 16 | A4D2G3 | |
| LIQPLFMFGVLLGSV | 156 | Q86VW1 | |
| GVLQLPQGLAFAMLA | 91 | P58743 | |
| MPNRLFFGNLGTILL | 131 | P48764 | |
| LPALFNIGLLLFLVM | 1641 | Q15858 | |
| LGFNALLQLMIGVPL | 261 | O75783 | |
| VLGGLFLLFVLENML | 291 | Q6ZMH5 | |
| FLNLPLQMFELGIVA | 746 | Q8N957 | |
| FGAGPLFNQILPLLM | 526 | O75533 | |
| MSLPALFNIGLLLFL | 1646 | Q9UQD0 | |
| GGLLMLLPAFVFIGL | 56 | P30408 | |
| MAGQRVLLLVGFLLP | 1 | Q3SY77 | |
| LINGAFLVLGLLFMG | 16 | P0C672 | |
| MGFQPPAALLLRLFL | 1 | Q96GX1 |